These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 10721978

  • 1. Cholesterosis following chemoreduction for advanced retinoblastoma.
    Gombos DS, Howes E, O'Brien JM.
    Arch Ophthalmol; 2000 Mar; 118(3):440-1. PubMed ID: 10721978
    [No Abstract] [Full Text] [Related]

  • 2. Residual intraretinal retinoblastoma after chemoreduction failure.
    Hwang CK, Aaberg TM, Chevez-Barrios P, Verner-Cole E, Gombos DS, Paysse E, Chintagumpala M, Gao W, Grossniklaus HE.
    Arch Ophthalmol; 2012 Feb; 130(2):246-8. PubMed ID: 22332223
    [No Abstract] [Full Text] [Related]

  • 3. Chemoreduction in the management of retinoblastoma.
    Shields JA, Shields CL, Meadows AT.
    Am J Ophthalmol; 2005 Sep; 140(3):505-6. PubMed ID: 16139001
    [No Abstract] [Full Text] [Related]

  • 4. Chemoreduction for unilateral retinoblastoma.
    Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Naduvilath TJ.
    Arch Ophthalmol; 2002 Dec; 120(12):1653-8. PubMed ID: 12470138
    [Abstract] [Full Text] [Related]

  • 5. Histopathologic findings in eyes with retinoblastoma treated only with chemoreduction.
    Demirci H, Eagle RC, Shields CL, Shields JA.
    Arch Ophthalmol; 2003 Aug; 121(8):1125-31. PubMed ID: 12912690
    [Abstract] [Full Text] [Related]

  • 6. Histopathologic changes in retinoblastoma after chemoreduction.
    Dithmar S, Aabert TM, Grossniklaus HE.
    Retina; 2000 Aug; 20(1):33-6. PubMed ID: 10696744
    [Abstract] [Full Text] [Related]

  • 7. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
    Gündüz K, Günalp I, Yalçindağ N, Unal E, Taçyildiz N, Erden E, Geyik PO.
    Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
    [Abstract] [Full Text] [Related]

  • 8. Clinicopathologic features of retinoblastoma after primary chemoreduction.
    Bechrakis NE, Bornfeld N, Schueler A, Coupland SE, Henze G, Foerster MH.
    Arch Ophthalmol; 1998 Jul; 116(7):887-93. PubMed ID: 9682701
    [Abstract] [Full Text] [Related]

  • 9. Chemoreduction plus focal therapy for retinoblastoma: factors predictive of need for treatment with external beam radiotherapy or enucleation.
    Shields CL, Honavar SG, Meadows AT, Shields JA, Demirci H, Singh A, Friedman DL, Naduvilath TJ.
    Am J Ophthalmol; 2002 May; 133(5):657-64. PubMed ID: 11992863
    [Abstract] [Full Text] [Related]

  • 10. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors.
    Shields CL, Mashayekhi A, Cater J, Shelil A, Meadows AT, Shields JA.
    Trans Am Ophthalmol Soc; 2004 May; 102():35-44; discussion 44-5. PubMed ID: 15747743
    [Abstract] [Full Text] [Related]

  • 11. Retinoblastoma: evidence for postenucleation adjuvant chemotherapy.
    Kim JW.
    Int Ophthalmol Clin; 2015 May; 55(1):77-96. PubMed ID: 25436495
    [No Abstract] [Full Text] [Related]

  • 12. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients.
    Shields CL, Shelil A, Cater J, Meadows AT, Shields JA.
    Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913
    [Abstract] [Full Text] [Related]

  • 13. The outcome of chemoreduction treatment in patients with Reese-Ellsworth group V retinoblastoma.
    Gündüz K, Shields CL, Shields JA, Meadows AT, Gross N, Cater J, Needle M.
    Arch Ophthalmol; 1998 Dec; 116(12):1613-7. PubMed ID: 9869790
    [Abstract] [Full Text] [Related]

  • 14. A perspective on chemoreduction and focal therapy for retinoblastoma.
    Balasubramanya R, Pushker N, Bajaj MS, Ghose S, Rani A.
    Am J Ophthalmol; 2002 Oct; 134(4):633; author reply 633-4. PubMed ID: 12383837
    [No Abstract] [Full Text] [Related]

  • 15. Macular retinoblastoma managed with chemoreduction: analysis of tumor control with or without adjuvant thermotherapy in 68 tumors.
    Shields CL, Mashayekhi A, Cater J, Shelil A, Ness S, Meadows AT, Shields JA.
    Arch Ophthalmol; 2005 Jun; 123(6):765-73. PubMed ID: 15955977
    [Abstract] [Full Text] [Related]

  • 16. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
    Zage PE, Reitman AJ, Seshadri R, Weinstein JL, Mets MB, Zeid JL, Greenwald MJ, Strauss LC, Goldman S.
    Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
    [Abstract] [Full Text] [Related]

  • 17. Expression of heat shock protein 27 and alpha-crystallins in human retinoblastoma after chemoreduction.
    Kase S, Parikh JG, Rao NA.
    Br J Ophthalmol; 2009 Apr; 93(4):541-4. PubMed ID: 18812387
    [Abstract] [Full Text] [Related]

  • 18. Anterior Segment Seeding in Eyes With Retinoblastoma Failing to Respond to Intraophthalmic Artery Chemotherapy.
    Pavlidou E, Burris C, Thaung C, Scheimberg I, Kingston J, Hungerford JL, Reddy MA, Sagoo MS.
    JAMA Ophthalmol; 2015 Dec; 133(12):1455-8. PubMed ID: 26334520
    [Abstract] [Full Text] [Related]

  • 19. Chemoreduction for retinoblastoma.
    Moll AC, Imhof SM, Schouten-van Meeteren AY, Boers M, van Leeuwen F, Hofman P.
    Arch Ophthalmol; 2003 Oct; 121(10):1513. PubMed ID: 14557204
    [No Abstract] [Full Text] [Related]

  • 20. [Results of combined chemoreduction and local treatment for intraocular retinoblastoma].
    Kobylarz J, Piwowarczyk A, Romanowska-Dixon B, Balwierz W, Dłuzniewska A.
    Klin Oczna; 2006 Oct; 108(1-3):55-9. PubMed ID: 16883942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.